72 related articles for article (PubMed ID: 23267141)
1. Intratumoural interleukin-2 therapy can induce regression of non-resectable mastocytoma in dogs.
Ziekman PG; Otter WD; Tan JF; Teske E; Kirpensteijn J; Koten JW; Jacobs JJ
Anticancer Res; 2013 Jan; 33(1):161-5. PubMed ID: 23267141
[TBL] [Abstract][Full Text] [Related]
2. Mast cell tumor destruction by deionized water.
Grier RL; Di Guardo G; Schaffer CB; Pedrosa B; Myers R; Merkley DF; Thouvenelle M
Am J Vet Res; 1990 Jul; 51(7):1116-20. PubMed ID: 2117868
[TBL] [Abstract][Full Text] [Related]
3. Treatment of transmissible venereal tumors in dogs with intratumoral interleukin-2 (IL-2). A pilot study.
Den Otter W; Hack M; Jacobs JJ; Tan JF; Rozendaal L; Van Moorselaar RJ
Anticancer Res; 2015 Feb; 35(2):713-7. PubMed ID: 25667450
[TBL] [Abstract][Full Text] [Related]
4. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
Taylor F; Gear R; Hoather T; Dobson J
J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
[TBL] [Abstract][Full Text] [Related]
5. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional study to investigate the association between vitamin D status and cutaneous mast cell tumours in Labrador retrievers.
Wakshlag JJ; Rassnick KM; Malone EK; Struble AM; Vachhani P; Trump DL; Tian L
Br J Nutr; 2011 Oct; 106 Suppl 1():S60-3. PubMed ID: 22005438
[TBL] [Abstract][Full Text] [Related]
7. Frequency and severity of mastocytemia in dogs with and without mast cell tumors: 120 cases (1995-1997).
McManus PM
J Am Vet Med Assoc; 1999 Aug; 215(3):355-7. PubMed ID: 10434973
[TBL] [Abstract][Full Text] [Related]
8. Advances in the diagnosis and management of cutaneous mast cell tumours in dogs.
Dobson JM; Scase TJ
J Small Anim Pract; 2007 Aug; 48(8):424-31. PubMed ID: 17559522
[TBL] [Abstract][Full Text] [Related]
9. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
Stanclift RM; Gilson SD
J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
[TBL] [Abstract][Full Text] [Related]
13. Electrochemotherapy compared to surgery for treatment of canine mast cell tumours.
Kodre V; Cemazar M; Pecar J; Sersa G; Cor A; Tozon N
In Vivo; 2009; 23(1):55-62. PubMed ID: 19368125
[TBL] [Abstract][Full Text] [Related]
14. Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.
Cicchelero L; Denies S; Haers H; Vanderperren K; Stock E; Van Brantegem L; de Rooster H; Sanders NN
Vet Comp Oncol; 2017 Dec; 15(4):1187-1205. PubMed ID: 27506827
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk and clinical outcome of mast cell tumours in pug dogs.
McNiel EA; Prink AL; O'Brien TD
Vet Comp Oncol; 2006 Mar; 4(1):2-8. PubMed ID: 19754824
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of canine mast cell tumors.
Pokorny E; Hecht S; Sura PA; LeBlanc AK; Phillips J; Conklin GA; Haifley KA; Newkirk K
Vet Radiol Ultrasound; 2012; 53(2):167-73. PubMed ID: 22136427
[TBL] [Abstract][Full Text] [Related]
17. Adverse haematological effects of vinblastine, prednisolone and cimetidine treatment: a retrospective study in fourteen dogs with mast cell tumours.
Trumel C; Bourgès-Abella N; Touron C; Lanore D; Geffré A; Diquelou A; Guelfi JF; Braun JP
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):275-9. PubMed ID: 16050908
[TBL] [Abstract][Full Text] [Related]
18. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival.
Krick EL; Billings AP; Shofer FS; Watanabe S; Sorenmo KU
Vet Comp Oncol; 2009 Jun; 7(2):130-8. PubMed ID: 19453367
[TBL] [Abstract][Full Text] [Related]
19. Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats.
Tozon N; Sersa G; Cemazar M
Anticancer Res; 2001; 21(4A):2483-8. PubMed ID: 11724311
[TBL] [Abstract][Full Text] [Related]
20. [Mast cell tumors in dogs--diagnosis and therapy of a malignant skin tumor].
Kessler M
Tierarztl Prax; 1995 Apr; 23(2):172-8. PubMed ID: 7624860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
